ArticleJournal of hepatology2013
Reply to: "Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling".
Charles D Howell et al.PubMed ↗Publisher ↗
No numbers read from the abstract.